A team of scientists has provided insight into the causes of severe brain disorders such as depression.
In organisms as complex as
humans, the neural mechanisms that help answer the question, "Is it
worth my effort?" can fail, leading to debilitating mental illnesses.
Major depressive disorder, for
instance, which affects nearly 20 percent of people at some point in
life, is correlated with underperformance in the parts of the brain
involved in motivation.
But Karl Deisseroth,
MD, PhD, a professor of bioengineering and of psychiatry and behavioral
sciences at Stanford University, and postdoctoral scholar Melissa
Warden, PhD, have struggled to work out the exact cause and effect.
Clinicians refer to this slowing down of motivation in depressed patients as "psychomotor retardation."
According to Deisseroth,
who is also a practicing psychiatrist, patients may experience this
symptom mentally, finding it hard to envision the positive results of an
action, or, he said, they may feel physically heavy, like their limbs
just do not want to move.
Psychiatrists, Deisseroth included, believe the will to act may be born in the prefrontal cortex
- the foremost part of the brain that helps plan and coordinate action.
It then zips through the brain as a series of electrical signals,
passing from neuron to neuron along countless branching pathways until
it reaches the nerves that directly implement movement.
Until this study, however, it was not clear which of these pathways
might control the willingness to meet challenges, or the anticipation
that action might be worthwhile in a difficult situation.
To isolate these pathways
relevant to depression, Deisseroth's team needed to stimulate specific
brain cells in rodents and observe changes in their behavior. They used
optogenetics, a technique Deisseroth developed at Stanford in 2005,
which has since revolutionized the fields of bioengineering and
neuroscience.
The secret is as old as green
algae. These single-celled organisms produce a protein called
channelrhodopsin that makes them sensitive to sunlight. Borrowing and
engineering the gene for this protein, Deisseroth has been able to
create neurons that respond to light delivered from fiber-optic cables.
He can turn the neurons on and off by sending bursts of light to
activate different areas of the brain and then observe the effects on
behavior.
Surprisingly, the researchers
found that simply stimulating the prefrontal cortices of rodents didn't
motivate them to try any harder in a laboratory challenge. It turns out
that motivation is not as simple as stimulating a region of the brain.
Instead of one switch in the prefrontal cortex that turns motivation on,
multiple switches work in concert. Some neurons excite motivated
activity and others inhibit it. Broadly stimulating the executive part
of the brain will not generate a simple effect on behavior.
"It's one step more subtle" said Deisseroth, "but this is something that optogenetics was very well-suited to resolve."
An optogenetic method called
projection targeting allowed the scientists to work backward from the
brain stem and find the exact pathway from neurons in the prefrontal
cortex that signal motivation.
The researchers first introduced
their light-sensitive protein into cells in the prefrontal cortex. The
light sensitivity then spread out like the branches of a tree through
all the outgoing connections and eventually made its way to the brain
stem, making those regions light sensitive, too.
Then, illuminating the newly
light-sensitive regions of the brain stem thought to control
motivational movement, Deisseroth and Warden watched the behavioral
effects as a subgroup of neurons in the prefrontal cortex that sent
connections to brain stem were activated. They could see not only which
cells are possibly involved in motivation, but the way motivation moves
from one brain region to another.
The researchers suspected that
one part of the brain stem in particular, the dorsal raphe nucleus,
might be crucial to behaviors that control effort. This cluster of cells
is a production hub for serotonin - a chemical messenger that changes
the firing behavior of other cells. Serotonin is associated with mood
modulation; many antidepressant drugs, for instance, may act by
increasing serotonin concentration in the brain.
When the pathway between the prefrontal cortex and the dorsal raphe
nucleus was stimulated, rodents facing a challenge in the lab showed an
immediate and dramatic surge in motivation.
Curiously, however, when the
rodents were relaxing in their home environment, the same stimulation
had no effect. The pathway was not merely linked to any action, or to
agitation; it was, more specifically, helping to "set the effort that
the organism was willing to put forth to meet a challenge," Deisseroth
said.
Researchers were also able to
produce the opposite effect - reduced effort in response to challenge -
by stimulating prefrontal neurons that project to the lateral habenula, a
region perched atop the brain stem that is thought to play a role in
depression. When this region was getting signals driven optogenetically
from the prefrontal cortex, rodents put forward less effort.
Connecting depressive symptoms
with brain pathways may be helpful in the development of drugs, but
according to Deisseroth, the most important part of this research is its
insight into how motivation works in both depressed and healthy people.

Post a Comment